Koh K K, Kim E J, Cho C H, Choi M J, Cho S K, Kim S S, Kim M H, Lee C J, Jin S H, Kim J M
Department of Internal Medicine, Inha University Hospital, Korea.
Circulation. 1994 Jun;89(6):2728-35. doi: 10.1161/01.cir.89.6.2728.
Adenosine deaminase (ADA) and carcinoembryonic antigen (CEA) have been measured in pleural fluid to help distinguish malignant from benign effusions, especially in tuberculous pleurisy. We investigated ADA and CEA levels in patients with moderate to large pericardial effusions of different etiologies.
We performed diagnostic and therapeutic pericardiostomy with drainage and biopsy. We measured ADA and CEA levels in the pericardial fluid in 26 patients with moderate to large pericardial effusion and 19 control patients. Patients were included in a prospective protocol from August 1991 to August 1993. Patients were grouped as follows: group 1, 9 patients with tuberculous pericarditis (TP) confirmed by bacteriologic culture or histology of pericardial biopsy; group 2, 5 patients with clinically strongly suspected TP; group 3, 12 patients with malignancy (8) and acute pericarditis (4); group 4, 19 control patients without pericardial disease. We treated patients with TP with isoniazid, rifampin, and either streptomycin or ethambutol for 12 months and pyrazinamide for 2 months. We observed for symptoms and signs of recurrent pericarditis or constrictive pericarditis on follow-up. In group 1 the ADA activity was significantly higher (101 +/- 14 U/L) than that in group 3 (22 +/- 5 U/L) or that in group 4 (17 +/- 2 U/L) (P < .05). There was no significant difference between ADA activity in group 1 (101 +/- 14 U/L) and that in group 2 (100 +/- 26 U/L). With a cutoff value for ADA activity of 40 U/L, sensitivity was 93% and specificity 97% in the diagnosis of TP. In benign diseases, the CEA level was significantly lower (1.0 +/- 0.3 ng/mL) than that in malignant diseases (135.1 +/- 79.7 ng/mL) (P < .05). With a cutoff value for CEA level of 5 ng/mL, sensitivity was 75% and specificity 100% in the diagnosis of malignant pericarditis. Follow-up study (mean, 12.9, 19.8, and 11.8 months in groups 1, 2, and 3, respectively, showed no symptoms or signs of constrictive pericarditis, except for 1 patient.
Pericardial fluid ADA and CEA are useful for the differential diagnosis of pericardial effusion of various causes. They also have great value in early diagnosis of TP, particularly when the results of other clinical and laboratory tests are negative.
已对胸腔积液中的腺苷脱氨酶(ADA)和癌胚抗原(CEA)进行检测,以帮助鉴别恶性与良性胸腔积液,尤其是在结核性胸膜炎中。我们研究了不同病因的中至大量心包积液患者的ADA和CEA水平。
我们进行了诊断性和治疗性心包造口引流及活检。我们检测了26例中至大量心包积液患者及19例对照患者心包液中的ADA和CEA水平。患者于1991年8月至1993年8月纳入前瞻性研究方案。患者分为以下几组:第1组,9例经心包活检细菌培养或组织学确诊为结核性心包炎(TP)的患者;第2组,5例临床高度怀疑为TP的患者;第3组,12例患有恶性肿瘤(8例)和急性心包炎(4例)的患者;第4组,19例无心包疾病的对照患者。我们用异烟肼、利福平以及链霉素或乙胺丁醇治疗TP患者12个月,并用吡嗪酰胺治疗2个月。随访观察复发性心包炎或缩窄性心包炎的症状和体征。第1组的ADA活性(101±14 U/L)显著高于第3组(22±5 U/L)或第4组(17±2 U/L)(P<.05)。第1组(101±14 U/L)和第2组(100±26 U/L)的ADA活性无显著差异。以ADA活性40 U/L为临界值,诊断TP的敏感性为93%,特异性为97%。在良性疾病中,CEA水平(1.0±0.3 ng/mL)显著低于恶性疾病(135.1±79.7 ng/mL)(P<.05)。以CEA水平5 ng/mL为临界值,诊断恶性心包炎的敏感性为75%,特异性为100%。随访研究(第1、2和3组的平均随访时间分别为12.9、19.8和11.8个月)显示,除1例患者外,均无缩窄性心包炎的症状或体征。
心包液ADA和CEA对各种病因的心包积液鉴别诊断有用。它们在TP的早期诊断中也具有重要价值,尤其是当其他临床和实验室检查结果为阴性时。